This small-cap pharma company backed by ace investor Ashish Kacholia had been the mutlibagger stock in 2021, as it surged over 1450 per cent to Rs 918 per share from Rs 59 per share on the BSE. The celebrity investor had made a fresh entry in the counter during the September quarter of this fiscal. 

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

The stock on the last day of 2021 has hit an upper circuit of 5 per cent to Rs 918 per share on the BSE intraday, as compared to over 1 per cent rise in the S&P BSE Sensex on Friday. 

See Zee Business Live TV Streaming Below:

The today’s surge in the stock is perhaps due to rising Covid cases in the country, as almost all pharmaceutical stocks from heavyweights to broader markets are surging in recent past. 

Ashish Kacholia, who is termed as big whale of the Indian stock market, has picked up 1.4 per cent stake, which comprises of 141,000 equity shares, the shareholding pattern on the BSE showed. 

Kacholia in the September quarter made a fresh entry in to at least 10 stocks, with an average investment of 1-1.5 per cent stake. He publicly holds 27 stocks with a net worth of over Rs 1,690.9 crore, as per the stock analysis website trendline.com. 

In the last six months, the scrip has given a return of over 450 per cent, as compared to 11 per cent surge in the S&P BSE Sensex during the same period. 

The other stocks that had also been a multibagger stock from Kacholia’s portfolio are Xpro India, Faze Three, Gateway Distriparks among others. 

The investor has bought increased his stake in the existing counters are Ador Welding, Garware Hi-Tech, Beta Drugs, IOL Chemicals and Safari industries. 

The pharma index in the current had been the top underperformed, as it surged mere 10 per cent in the last one year, while it reported flat with negative bias growth during the last six months.